<PAPER><mode2 name='PMC3199881' hasDoc='yes' version='597'></mode2><article xmlns:mml='http://www.w3.org/1998/Math/MathML' xmlns:xlink='http://www.w3.org/1999/xlink' article-type='research-article'><front><journal-meta><journal-id journal-id-type='nlm-ta'>Dement Geriatr Cogn Dis Extra</journal-id><journal-id journal-id-type='publisher-id'>DEE</journal-id><journal-title-group><journal-title>Dementia and Geriatric Cognitive Disorders EXTRA</journal-title></journal-title-group><issn pub-type='epub'>1664-5464</issn><publisher><publisher-name>S. Karger AG</publisher-name><publisher-loc>Allschwilerstrasse 10, P.O. Box · Postfach · Case postale, CH–4009, Basel, Switzerland · Schweiz · Suisse, Phone: +41 61 306 11 11, Fax: +41 61 306 12 34, karger@karger.ch</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type='pmcid'>3199881</article-id><article-id pub-id-type='pmid'>22163247</article-id><article-id pub-id-type='doi'>10.1159/000329447</article-id><article-id pub-id-type='publisher-id'>dee0001-0228</article-id><article-categories><subj-group subj-group-type='heading'><subject>Original Research Article</subject></subj-group></article-categories><title-group><article-title><s sid='1'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Goa1' type='Goa'></CoreSc1>Asymmetric Cerebral Blood Flow in Patients with Mild Cognitive Impairment: Possible Relationship to Further Cognitive Deterioration</s></article-title></title-group><contrib-group><contrib contrib-type='author'><name><surname>Edman</surname><given-names>Åke</given-names></name><xref rid='aff1' ref-type='aff'><sup>a</sup></xref><xref rid='cor1' ref-type='corresp'>*</xref></contrib><contrib contrib-type='author'><name><surname>Edenbrandt</surname><given-names>Lars</given-names></name><xref rid='aff2' ref-type='aff'><sup>b</sup></xref><xref rid='aff3' ref-type='aff'><sup>c</sup></xref></contrib><contrib contrib-type='author'><name><surname>Fredén-Lindqvist</surname><given-names>Johan</given-names></name><xref rid='aff2' ref-type='aff'><sup>b</sup></xref></contrib><contrib contrib-type='author'><name><surname>Nilsson</surname><given-names>Magnus</given-names></name><xref rid='aff2' ref-type='aff'><sup>b</sup></xref></contrib><contrib contrib-type='author'><name><surname>Wallin</surname><given-names>Anders</given-names></name><xref rid='aff1' ref-type='aff'><sup>a</sup></xref></contrib></contrib-group><aff id='aff1'><sup>a</sup>Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, Malmö, Sweden</aff><aff id='aff2'><sup>b</sup>Department of Molecular and Clinical Medicine, Clinical Physiology, Sahlgrenska University Hospital, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Malmö, Sweden</aff><aff id='aff3'><sup>c</sup>Department of Clinical Sciences, Lund University, Malmö, Sweden</aff><author-notes><corresp id='cor1'>*Åke Edman, Vuxenpsykiatriska mottagningen, Träslövsvägen 25B, SE–43243 Varberg (Sweden), Tel. +46 340 482 411, E-Mail <email>ake.edman@neuro.gu.se</email></corresp></author-notes><pub-date pub-type='collection'><season>Jan-Dec</season><year>2011</year></pub-date><pub-date pub-type='epub'><day>29</day><month>7</month><year>2011</year></pub-date><pub-date pub-type='pmc-release'><day>29</day><month>7</month><year>2011</year></pub-date><volume>1</volume><issue>1</issue><fpage>228</fpage><lpage>236</lpage><permissions><copyright-statement>Copyright © 2011 by S. Karger AG, Basel</copyright-statement><copyright-year>2011</copyright-year><license license-type='open-access' xlink:href='http://creativecommons.org/licenses/by-nc-nd/3.0/'><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License (<ext-link ext-link-type='uri' xlink:href='http://creativecommons.org/licenses/by-nc-nd/3.0/'>http://creativecommons.org/licenses/by-nc-nd/3.0/</ext-link>). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on <ext-link ext-link-type='uri' xlink:href='http://www.karger.com'>http://www.karger.com</ext-link> and the terms of this license are included in any shared versions.</license-p></license></permissions><abstract><sec><title>Aim</title><p><s sid='2'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Goa1' type='Goa'></CoreSc1>To explore patterns of cerebral blood flow in patients with mild cognitive impairment (MCI), who (1) eventually deteriorate into overt dementia, with no particular focus on the type of dementia, or (2) do not appear to further deteriorate in their cognitive functions.</s></p></sec><sec><title>Methods</title><p><s sid='3'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1>Thirty-seven MCI patients, with or without vascular pathology, were studied prospectively.</s><s sid='4'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The patients underwent <sup>99m</sup>Tc-HMPAO SPECT analysis at baseline.</s><s sid='5'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Possible clinical conversion into dementia within a 2-year period was assessed.</s></p></sec><sec><title>Results</title><p><s sid='6'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1>Nineteen patients had progressive MCI (PMCI), while 18 patients were considered clinically stable (SMCI).</s><s sid='7'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> PMCI patients had more often abnormally low cerebral blood flow in at least one of the frontal, temporal, parietal or occipital lobes compared to SMCI patients (12/19 vs. 5/18; p = 0.049).</s><s sid='8'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> At least one of the temporal regions was found to be abnormal in 9 PMCI patients in contrast to only 1 SMCI patient (p = 0.008).</s><s sid='9'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> More specifically, blood flow in the medial portion of the left temporal region was abnormal in 8 PMCI patients, a pattern seen in 1 SMCI patient only (p = 0.019).</s></p></sec><sec><title>Conclusion</title><p><s sid='10'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1>The results suggest that blood flow reductions particularly in the left medial temporal region indicate an elevated risk of further cognitive decline in MCI patients.</s></p></sec></abstract><kwd-group><title>Key Words</title><kwd>Cerebral blood flow</kwd><kwd>Cognitive decline</kwd><kwd>Mild cognitive impairment</kwd><kwd>Progressive dementia</kwd><kwd>SPECT</kwd></kwd-group><counts><table-count count='4'></table-count><ref-count count='36'></ref-count><page-count count='9'></page-count></counts></article-meta></front><body><sec id='sec1_1'><title>Introduction</title><p><s sid='11'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>Mild cognitive impairment (MCI) represents a borderline condition between normal cognition and dementia.</s><s sid='12'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Subjects with MCI are at a higher risk of converting into overt dementia than subjects with normal cognition [<xref rid='B1' ref-type='bibr'>1</xref>,<xref rid='B2' ref-type='bibr'>2</xref>].</s><s sid='13'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Since Alzheimer's disease (AD) is considered to be the most common form of dementia [<xref rid='B3' ref-type='bibr'>3</xref>], prodromal AD is probably the most frequent single MCI disorder.</s><s sid='14'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> However, MCI is most likely a heterogeneous condition, i.e. an MCI patient who further deteriorates in his/her cognitions into overt dementia may develop one of many possible dementia disorders [<xref rid='B4' ref-type='bibr'>4</xref>].</s><s sid='15'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Mot1' type='Mot'></CoreSc1> It would, therefore, seem relevant to study the eventual cognitive outcome in MCI patients with focus not only on AD, the presence or absence of which has been the endpoint in the vast majority of studies on MCI progression.</s></p><p><s sid='16'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>It is probable that several dementia treatments with curative intention will be available in the fairly near future [<xref rid='B5' ref-type='bibr'>5</xref>,<xref rid='B6' ref-type='bibr'>6</xref>].</s><s sid='17'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> In this context, there is reason to believe that the patient would benefit from treatment intervention already in the early phases of progressive cognitive disorders.</s><s sid='18'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Mot1' type='Mot'></CoreSc1> It is important, therefore, to acquire knowledge on markers for progressive degenerative and vascular pathogenesis already in the incipient stages of dementia.</s><s sid='19'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Mot1' type='Mot'></CoreSc1> Conversely, it is equally important to acquire knowledge on markers for non-progressive cognitive disorder.</s></p><p><s sid='20'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>Magnetic resonance imaging studies have revealed an association between hippocampal atrophy and later development into overt dementia [<xref rid='B7' ref-type='bibr'>7</xref>], whereby left hippocampal atrophy may be a particularly sensitive predictor [<xref rid='B8' ref-type='bibr'>8</xref>].</s><s sid='21'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Furthermore, it has been demonstrated that the cerebrospinal fluid biomarker levels of τ, phosphorylated τ and amyloid β<sub>1–42</sub> (Aβ<sub>42</sub>) are altered already at the MCI stages in patients who will, eventually, suffer from AD [<xref rid='B9' ref-type='bibr'>9</xref>,<xref rid='B10' ref-type='bibr'>10</xref>,<xref rid='B11' ref-type='bibr'>11</xref>].</s></p><p><s sid='22'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>Results from prospective FDG-PET studies suggest that subnormal metabolic rates of glucose consumption in temporoparietal and hippocampal regions in MCI patients [<xref rid='B12' ref-type='bibr'>12</xref>] predict future conversion into overt AD.</s><s sid='23'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> In a prospective study on cerebral blood flow imaging with SPECT, blood flow reductions in several brain regions, including the parietal and temporal lobes and posterior cingulate, appeared to indicate future conversion from MCI into AD [<xref rid='B13' ref-type='bibr'>13</xref>].</s></p><p><s sid='24'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Goa1' type='Goa'></CoreSc1>The aim of the present prospective study was to further explore possible patterns of cerebral blood flow reduction in a clinical population of MCI patients, who (1) eventually deteriorate into overt dementia, or (2) do not appear to further deteriorate in their cognitive functions.</s><s sid='25'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1> Patients with vascular pathology were not excluded, except for patients with a history of cerebral stroke.</s><s sid='26'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Separate quantification of left and right medial temporal lobe blood flow was included in the protocol.</s><s sid='27'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Blood flow was measured by way of hexamethyl propylene amine oxime (HMPAO)-SPECT, a technique which is relatively simple and widespread in medical care in comparison with the PET technique.</s><s sid='28'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Hyp1' type='Hyp'></CoreSc1> Results from blood flow studies that utilize SPECT, instead of PET (which enables a higher-power resolution), may therefore be of more immediate importance in medical care.</s></p></sec><sec sec-type='materials|methods' id='sec1_2'><title>Materials and Methods</title><sec id='sec2_1'><title>Study Population</title><p><s sid='29'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1>Thirty-seven patients with MCI were studied.</s><s sid='30'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1> They were part of the Gothenburg MCI Study, which is a longitudinal study on MCI and mild dementia performed at the Department of Neuropsychiatry, Göteborg University, Sweden, and approved by the Ethics Committee of the University (reference: L 091-99).</s><s sid='31'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> The patients had given their informed consent.</s><s sid='32'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1> Those included in the present study were the first consecutive subjects who (1) underwent SPECT analysis at baseline; (2) were assessed for MCI with a baseline score of 3 on the Global Deterioration Scale (GDS), and (3) did not have a history of major stroke.</s></p><p><s sid='33'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>The categorization of patients with regard to MCI and (unspecified) dementia was based on anamnestic data and checklists for cognitive assessment: (1) Stepwise Comparative Status Analysis (STEP) [<xref rid='B14' ref-type='bibr'>14</xref>], variables 13–20 (memory disturbance, disorientation, reduced abstract thinking, visuospatial disturbance, poverty of language, sensory aphasia, visual agnosia, and apraxia); (2) IFlex, which is a short form of the Executive Interview [<xref rid='B15' ref-type='bibr'>15</xref>] (number-letter task, word fluency, anomalous sentence repetition, interference task, Luria's hand sequences, and counting task); (3) Mini-Mental State Examination (MMSE) [<xref rid='B16' ref-type='bibr'>16</xref>], and (4) Clinical Dementia Rating (CDR) [<xref rid='B17' ref-type='bibr'>17</xref>].</s><s sid='34'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The CDR assessment was based on information from both the subject and an informant.</s><s sid='35'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> For inclusion, subjective and objective (by an informant) verifications of a progressive cognitive impairment for &gt;6 months were required.</s><s sid='36'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> In addition, a positive outcome on STEP, IFlex, MMSE or CDR was required.</s><s sid='37'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Subjects with &gt;2 positive outcomes on STEP or a score &lt;25 on the MMSE were considered to fulfill criteria for dementia and were, consequently, not included in the present study [<xref rid='B18' ref-type='bibr'>18</xref>].</s><s sid='38'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> The above algorithm is congruent with recent diagnostic recommendations [<xref rid='B2' ref-type='bibr'>2</xref>].</s><s sid='39'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Based on the scores, patients were classified according to the GDS where 3 equals MCI and 4 mild dementia [<xref rid='B19' ref-type='bibr'>19</xref>].</s></p><p><s sid='40'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>Nineteen patients converted clinically into dementia within 2 years (progressive MCI, PMCI), while 18 patients were considered clinically stable during the same time period (stable MCI, SMCI).</s><s sid='41'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Conversion into the dementia syndrome was assessed according to the algorithm outlined above.</s><s sid='42'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> The patients who converted to dementia suffered from the following clinical disorders: AD (n = 7) according to the NINCDS-ADRDA criteria [<xref rid='B20' ref-type='bibr'>20</xref>], subcortical vascular dementia, SVD, (n = 3) according to the criteria of Erkinjuntti et al. [<xref rid='B21' ref-type='bibr'>21</xref>], mixed AD/(subcortical) vascular dementia, MD (n = 7), progressive non-fluent aphasia (n = 1) according to the criteria of Neary et al. [<xref rid='B22' ref-type='bibr'>22</xref>], and dementia non-ultra descriptum where no particular dementia disorder was possible to identify clinically (n = 1).</s><s sid='43'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Baseline demographics are presented in table <xref rid='T1' ref-type='table'>1</xref>.</s><s sid='44'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> No statistical difference was found between the PMCI and SMCI groups with regard to age, gender, or baseline performance on MMSE.</s></p><p><s sid='45'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>SPECT analysis was not included in any diagnostic procedure.</s></p></sec><sec id='sec2_2'><title>SPECT Imaging</title><p><s sid='46'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1>All patients underwent <sup>99m</sup>Tc-HMPAO SPECT at baseline.</s><s sid='47'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> About 1,000 MBq of <sup>99m</sup>Tc-HMPAO was administered intravenously after a 15- to 20-min period of resting in a quiet and dimly lit room.</s><s sid='48'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> The subjects had their eyes closed during the resting period and the injection.</s><s sid='49'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Imaging acquisitions were performed with a 3-headed Picker Irix γ-camera (Philips Medical Systems Inc., Hamburg, Germany) with high-resolution collimators about 45 min after the injection.</s><s sid='50'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> A 128 × 128 pixel matrix was used and 90 projections were registered with an acquisition time of 45 s each.</s><s sid='51'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The image reconstruction was performed with filtered back-projection and a Butterworth filter (cutoff 0.5 cycles/cm) on a Picker Odyssey FX820 System (Philips Medical Systems Inc).</s><s sid='52'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Attenuation was modeled to be uniform (linear attenuation coefficient = 0.11 cm<sup>−1</sup>) inside the skull volume.</s><s sid='53'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> No scatter subtraction was performed.</s><s sid='54'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The resulting transaxial slice images were then transferred to a software for semiquantitative analysis (EXINI brain<sup>TM</sup>; EXINI diagnostics AB, Lund, Sweden).</s><s sid='55'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> The software comprises a 3-dimensional method based on a brain-shaped model and the active shape algorithm.</s><s sid='56'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> The method defines the surface shape of the brain and then projects the maximum counts 0–1.5 cm deep for designated surface points.</s><s sid='57'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> These surface projection values are divided into cortical regions representing the different lobes and presented relative to the whole cortex, cerebellum, or cerebellar maximum.</s><s sid='58'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The whole brain and the cerebellum are the most common reference regions used, but they do not always represent the best choice.</s><s sid='59'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> In patients with reduced blood flow in these regions, quantitative data may be inaccurate.</s><s sid='60'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> As an alternative reference region, the maximum value of the cerebellum was added to the quantification method.</s></p><p><s sid='61'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>The mean time between baseline clinical assessment and SPECT imaging was 140 (SD 77) days in the PMCI group and 105 (SD 81) days in the SMCI group; the difference is statistically not significant (p = 0.187).</s></p></sec><sec id='sec2_3'><title>Image Analysis</title><p><s sid='62'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>The brain surface is automatically outlined 3-dimensionally by the program.</s><s sid='63'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The cortical blood flow is calculated in relation to the blood flow of one of three reference regions (cortex – the whole cortical part of the brain; cerebellum<sub>tot</sub> – the cortical part of cerebellum, and cerebellum<sub>max</sub> – the maximum intensity of cerebellum).</s><s sid='64'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The relative blood flow values are compared to the corresponding values of a normal database and z-values are calculated.</s><s sid='65'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1> The normal group consisted of 30 healthy volunteers, 20 females and 10 males, with a mean age of 74.4 years (SD 7.8; range 64–98).</s><s sid='66'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Mean z-values are calculated of each of 10 brain regions (frontal lobe dx/sin/med, temporal lobe dx/sin/med-dx/med-sin), parietal lobe (dx/sin) and the whole occipital lobe.</s><s sid='67'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The differences in blood flow between the left and right sides are also calculated for the frontal, temporal and parietal lobes, and compared to the corresponding normal values.</s></p></sec><sec id='sec2_4'><title>Statistical Analyses</title><p><s sid='68'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>Relationships between categorical variables were tested using Fisher's exact test and relationships between continuous variables were tested using Student's t test.</s></p></sec></sec><sec id='sec1_3'><title>Results</title><p><s sid='69'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>The number of patients with abnormal baseline findings in the parietal, temporal, frontal, and occipital lobes are presented in table <xref rid='T2' ref-type='table'>2</xref>.</s><s sid='70'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Patients with PMCI had more frequently abnormal findings in the cerebral blood flow in at least 1 of the 4 regions compared to the SMCI group (12/19 vs. 5/18; p = 0.049), using the cerebellum<sub>max</sub> normalization method.</s><s sid='71'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> The 12 cases included 4 of the 7 AD patients and 7 of the 10 dementia patients with obvious cerebrovascular disease (SVD + MD; non-significant difference between the patient groups).</s><s sid='72'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> The 17 patients with reduced blood flow had a mean MMSE of 27.8 compared to a mean MMSE of 27.6 in the remaining patients without reduced blood flow.</s><s sid='73'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> This difference was not significant, i.e. a relationship between cognitive performance and reduced blood flow could not be found.</s><s sid='74'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> At least one of the temporal regions was abnormal in 9 of the PMCI patients, but only in 1 SMCI patient using the same normalization method (p = 0.008).</s><s sid='75'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> The 9 cases included 2 of the 7 AD patients and 6 of the 10 SVD + MD patients (non-significant difference between the patient groups).</s><s sid='76'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> More specifically, the blood flow in the medial portion of the left temporal region was abnormally low in 8 PMCI patients, a pattern seen only in 1 SMCI patient (p = 0.019).</s><s sid='77'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> There were no significant differences in blood flow between the patient groups in the frontal, parietal, and occipital lobes.</s></p><p><s sid='78'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>Measurements of relative blood flow as a continuous variable are presented in table <xref rid='T3' ref-type='table'>3</xref>.</s><s sid='79'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> No differences in mean z-values (standard deviations from the mean of a normal database) between PMCI and SMCI were found in the parietal, temporal, frontal, or occipital lobes.</s></p><p><s sid='80'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>In addition, a significant side difference in cerebral blood flow was found in 11 patients, 7 PMCI (3 MD, 2 AD, 1 SVD, and 1 progressive non-fluent aphasia) and 4 SMCI (table <xref rid='T4' ref-type='table'>4</xref>).</s><s sid='81'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> In all cases, the cerebral blood flow was lower on the left compared to the right side.</s></p></sec><sec id='sec1_4'><title>Discussion</title><p><s sid='82'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1>The present study demonstrated that MCI patients who deteriorated into overt dementia within the following 2-year period exhibited more often abnormal cerebral blood flow at baseline than did patients with SMCI.</s><s sid='83'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> The most distinct finding was a blood flow reduction in the medial portion of the left temporal region in 8 of 19 PMCI patients, a pattern seen in 1 of 18 SMCI patients only (using the cerebellum<sub>max</sub> method).</s></p><p><s sid='84'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>We did not find any significant differences in the measurements of relative blood flow as a continuous variable between the PMCI and SMCI groups.</s><s sid='85'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The analysis was made separately for the frontal, temporal, parietal and occipital lobes.</s><s sid='86'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> Abnormal findings in at least one of these regions were, however, more frequent in the PMCI group compared to the SMCI group.</s><s sid='87'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> This finding indicates that the PMCI patients are a heterogeneous group and that abnormalities in their cerebral blood flow can appear in different locations rather than as a homogeneous gradual decrease in blood flow in a specific location.</s></p><p><s sid='88'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>It is fairly well established that blood flow reductions in parietal brain regions, medial temporal regions, precuneus and posterior cingulate gyrus predict cognitive decline [<xref rid='B13' ref-type='bibr'>13</xref>,<xref rid='B23' ref-type='bibr'>23</xref>,<xref rid='B24' ref-type='bibr'>24</xref>,<xref rid='B25' ref-type='bibr'>25</xref>] and the development of clinically manifest AD in MCI patients [<xref rid='B26' ref-type='bibr'>26</xref>].</s><s sid='89'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Also, the presence of AD-typical cortical atrophy on MRI appears to predict future cognitive deterioration in patients with MCI [<xref rid='B27' ref-type='bibr'>27</xref>].</s><s sid='90'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> With regard to the possible importance of asymmetrical blood flow patterns, presence of left-sided reduction in the posterior cingulate gyrus has been reported in a SPECT study on PMCI [<xref rid='B28' ref-type='bibr'>28</xref>].</s><s sid='91'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Also, a SPECT study by Nobili et al. [<xref rid='B29' ref-type='bibr'>29</xref>] demonstrated reduced blood flow in the left hippocampusin amnestic MCI.</s><s sid='92'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Conversely, another SPECT study demonstrated right-sided parietal and hippocampal blood flow reductions in PMCI [<xref rid='B30' ref-type='bibr'>30</xref>].</s><s sid='93'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> One study employing functional MRI demonstrated <italic>increased</italic> blood flow in the left hippocampus in MCI, a finding which was interpreted as a possible (transient) compensatory mechanism in incipient AD [<xref rid='B31' ref-type='bibr'>31</xref>].</s><s sid='94'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> In summary, the present study and the literature provide results which appear to be contradictory with regard to the existence and possible importance of asymmetrical cerebral blood flow in MCI.</s></p><p><s sid='95'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1>There was no significant difference in frontal lobe blood flow between PMCI and SMCI patients in the present study.</s><s sid='96'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> This finding is in contrast to findings in SPECT studies by Huang et al. [<xref rid='B23' ref-type='bibr'>23</xref>,<xref rid='B24' ref-type='bibr'>24</xref>], in which blood flow in frontal brain regions of PMCI patients was increased compared with SMCI patients and healthy controls.</s><s sid='97'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> In a recent MR/SPECT study on amnestic MCI [<xref rid='B32' ref-type='bibr'>32</xref>], a <italic>negative</italic> correlation was found between entorhinal/hippocampal volumes and blood flow in frontal brain regions – and a <italic>positive</italic> correlation between entorhinal/hippocampal volumes and blood flow in the posterior cingulate gyrus, whereby the latter finding possibly reflects deafferentation.</s><s sid='98'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Taken together, the above results in the literature indicate the presence of transient compensatory frontal functions in subgroups of MCI patients prior to conversion into overt dementia.</s></p><p><s sid='99'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1>In conclusion, the results of the present study support the view that blood flow reductions in the left medial temporal region indicate an elevated risk of further cognitive decline in MCI patients.</s><s sid='100'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Unfortunately, the SPECT literature in the field of MCI prognostics reports the use of varying progression markers and varying brain regions of interest.</s><s sid='101'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Furthermore, inclusion criteria may vary.</s><s sid='102'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> In the present study, for instance, information on left/right handedness was not included in the protocol.</s><s sid='103'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> These circumstances make comparisons between studies somewhat difficult [<xref rid='B33' ref-type='bibr'>33</xref>].</s></p><p><s sid='104'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>Finally, a note on the choice of the imaging method is worth being mentioned.</s><s sid='105'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> FDG-PET, one alternative imaging technique, appears to be a more distinct marker of cognitive decline compared to SPECT [<xref rid='B33' ref-type='bibr'>33</xref>].</s><s sid='106'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> The FDG-PET technique appears to have the ability even to predict future MCI in clinically healthy persons [<xref rid='B34' ref-type='bibr'>34</xref>].</s><s sid='107'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Furthermore, Pittsburgh Compound-B PET appears to be a promising method for early identification of emerging AD [<xref rid='B35' ref-type='bibr'>35</xref>,<xref rid='B36' ref-type='bibr'>36</xref>].</s><s sid='108'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> However, the SPECT technique is in most countries more often available than PET.</s><s sid='109'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Data from prediction studies based on SPECT and robust assessments of cognitive status, such as GDS, would, therefore, possibly be of more immediate importance in general health care.</s></p></sec><sec id='sec1_5'><title>Disclosure Statement</title><p>Lars Edenbrandt is employed and shareholder in EXINI diagnostics AB, which owns the software EXINI brain described in this paper.</p></sec></body><back><ack><title>Acknowledgements</title><p>The authors thank Ms. Eva Bringman, Ms. Christina Holmberg and Ms. Ewa Styrud for excellent assistance in the study, and Mr. Mattias Göthlin for expert database handling. This study was supported by grants from the Alzheimerfonden, Demensförbundet, Sahlgrenska University Hospital, Stiftelsen Psykiatriska forskningsfonden, Swedish Brain Power and the Swedish Research Council.</p></ack><ref-list><title>References</title><ref id='B1'><label>1</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Petersen</surname><given-names>RC</given-names></name></person-group><article-title>Mild cognitive impairment as a diagnostic entity</article-title><source>J Intern Med</source><year>2004</year><volume>256</volume><fpage>183</fpage><lpage>194</lpage><pub-id pub-id-type='pmid'>15324362</pub-id></element-citation></ref><ref id='B2'><label>2</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Winblad</surname><given-names>B</given-names></name><name><surname>Palmer</surname><given-names>K</given-names></name><name><surname>Kivipelto</surname><given-names>M</given-names></name><name><surname>Jelic</surname><given-names>V</given-names></name><name><surname>Fratiglioni</surname><given-names>L</given-names></name><name><surname>Wahlund</surname><given-names>LO</given-names></name><name><surname>Nordberg</surname><given-names>A</given-names></name><name><surname>Backman</surname><given-names>L</given-names></name><name><surname>Albert</surname><given-names>M</given-names></name><name><surname>Almkvist</surname><given-names>O</given-names></name><name><surname>Arai</surname><given-names>H</given-names></name><name><surname>Basun</surname><given-names>H</given-names></name><name><surname>Blennow</surname><given-names>K</given-names></name><name><surname>de Leon</surname><given-names>M</given-names></name><name><surname>DeCarli</surname><given-names>C</given-names></name><name><surname>Erkinjuntti</surname><given-names>T</given-names></name><name><surname>Giacobini</surname><given-names>E</given-names></name><name><surname>Graff</surname><given-names>C</given-names></name><name><surname>Hardy</surname><given-names>J</given-names></name><name><surname>Jack</surname><given-names>C</given-names></name><name><surname>Jorm</surname><given-names>A</given-names></name><name><surname>Ritchie</surname><given-names>K</given-names></name><name><surname>van Duijn</surname><given-names>C</given-names></name><name><surname>Visser</surname><given-names>P</given-names></name><name><surname>Petersen</surname><given-names>RC</given-names></name></person-group><article-title>Mild cognitive impairment – beyond controversies, towards a consensus: report of the international working group on mild cognitive impairment</article-title><source>J Intern Med</source><year>2004</year><volume>256</volume><fpage>240</fpage><lpage>246</lpage><pub-id pub-id-type='pmid'>15324367</pub-id></element-citation></ref><ref id='B3'><label>3</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Ferri</surname><given-names>CP</given-names></name><name><surname>Prince</surname><given-names>M</given-names></name><name><surname>Brayne</surname><given-names>C</given-names></name><name><surname>Brodaty</surname><given-names>H</given-names></name><name><surname>Fratiglioni</surname><given-names>L</given-names></name><name><surname>Ganguli</surname><given-names>M</given-names></name><name><surname>Hall</surname><given-names>K</given-names></name><name><surname>Hasegawa</surname><given-names>K</given-names></name><name><surname>Hendrie</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Jorm</surname><given-names>A</given-names></name><name><surname>Mathers</surname><given-names>C</given-names></name><name><surname>Menezes</surname><given-names>PR</given-names></name><name><surname>Rimmer</surname><given-names>E</given-names></name><name><surname>Scazufca</surname><given-names>M</given-names></name><collab>Alzheimer's Disease International</collab></person-group><article-title>Global prevalence of dementia: a Delphi consensus study</article-title><source>Lancet</source><year>2005</year><volume>366</volume><fpage>2112</fpage><lpage>2117</lpage><pub-id pub-id-type='pmid'>16360788</pub-id></element-citation></ref><ref id='B4'><label>4</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Maioli</surname><given-names>F</given-names></name><name><surname>Coveri</surname><given-names>M</given-names></name><name><surname>Pagni</surname><given-names>P</given-names></name><name><surname>Chiandetti</surname><given-names>C</given-names></name><name><surname>Marchetti</surname><given-names>C</given-names></name><name><surname>Ciarrocchi</surname><given-names>R</given-names></name><name><surname>Ruggero</surname><given-names>C</given-names></name><name><surname>Nativio</surname><given-names>V</given-names></name><name><surname>Onesti</surname><given-names>A</given-names></name><name><surname>D'Anastasio</surname><given-names>C</given-names></name><name><surname>Pedone</surname><given-names>V</given-names></name></person-group><article-title>Conversion of mild cognitive impairment to dementia in elderly subjects: a preliminary study in a memory and cognitive disorder unit</article-title><source>Arch Gerontol Geriatr</source><year>2007</year><volume>44</volume><issue>suppl 1</issue><fpage>233</fpage><lpage>241</lpage><pub-id pub-id-type='pmid'>17317458</pub-id></element-citation></ref><ref id='B5'><label>5</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Bergmans</surname><given-names>BA</given-names></name><name><surname>De Strooper</surname></name></person-group><article-title>Gamma-secretases: from cell biology to therapeutic strategies</article-title><source>Lancet Neurol</source><year>2010</year><volume>9</volume><fpage>215</fpage><lpage>226</lpage><pub-id pub-id-type='pmid'>20129170</pub-id></element-citation></ref><ref id='B6'><label>6</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Lemere</surname><given-names>CA</given-names></name><name><surname>Masliah</surname><given-names>E</given-names></name></person-group><article-title>Can Alzheimer disease be prevented by amyloid-beta immunotherapy?</article-title><source>Nat Rev Neurol</source><year>2010</year><volume>6</volume><fpage>108</fpage><lpage>119</lpage><pub-id pub-id-type='pmid'>20140000</pub-id></element-citation></ref><ref id='B7'><label>7</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Pihlajamäki</surname><given-names>M</given-names></name><name><surname>Jauhiainen</surname><given-names>AM</given-names></name><name><surname>Soininen</surname><given-names>H</given-names></name></person-group><article-title>Structural and functional MRI in mild cognitive impairment</article-title><source>Curr Alzheimer Res</source><year>2009</year><volume>6</volume><fpage>179</fpage><lpage>185</lpage><pub-id pub-id-type='pmid'>19355853</pub-id></element-citation></ref><ref id='B8'><label>8</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Eckerström</surname><given-names>C</given-names></name><name><surname>Olsson</surname><given-names>E</given-names></name><name><surname>Borga</surname><given-names>M</given-names></name><name><surname>Ekholm</surname><given-names>S</given-names></name><name><surname>Ribbelin</surname><given-names>S</given-names></name><name><surname>Rolstad</surname><given-names>S</given-names></name><name><surname>Starck</surname><given-names>G</given-names></name><name><surname>Edman</surname><given-names>A</given-names></name><name><surname>Wallin</surname><given-names>A</given-names></name><name><surname>Malmgren</surname><given-names>H</given-names></name></person-group><article-title>Small baseline volume of left hippocampus is associated with subsequent conversion of MCI into dementia: the Göteborg MCI study</article-title><source>J Neurol Sci</source><year>2008</year><volume>272</volume><fpage>48</fpage><lpage>59</lpage><pub-id pub-id-type='pmid'>18571674</pub-id></element-citation></ref><ref id='B9'><label>9</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Herukka</surname><given-names>SK</given-names></name><name><surname>Hallikainen</surname><given-names>M</given-names></name><name><surname>Soininen</surname><given-names>H</given-names></name><name><surname>Pirttilä</surname><given-names>T</given-names></name></person-group><article-title>CSF Aβ42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment</article-title><source>Neurology</source><year>2005</year><volume>64</volume><fpage>1294</fpage><lpage>1297</lpage><pub-id pub-id-type='pmid'>15824371</pub-id></element-citation></ref><ref id='B10'><label>10</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Hansson</surname><given-names>O</given-names></name><name><surname>Zetterberg</surname><given-names>H</given-names></name><name><surname>Buchhave</surname><given-names>P</given-names></name><name><surname>Londos</surname><given-names>E</given-names></name><name><surname>Blennow</surname><given-names>K</given-names></name><name><surname>Minthon</surname><given-names>L</given-names></name></person-group><article-title>Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study</article-title><source>Lancet Neurol</source><year>2006</year><volume>5</volume><fpage>228</fpage><lpage>234</lpage><pub-id pub-id-type='pmid'>16488378</pub-id></element-citation></ref><ref id='B11'><label>11</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Visser</surname><given-names>PJ</given-names></name><name><surname>Verhey</surname><given-names>F</given-names></name><name><surname>Knol</surname><given-names>DL</given-names></name><name><surname>Scheltens</surname><given-names>P</given-names></name><name><surname>Wahlund</surname><given-names>LO</given-names></name><name><surname>Freund-Levi</surname><given-names>Y</given-names></name><name><surname>Tsolaki</surname><given-names>M</given-names></name><name><surname>Minthon</surname><given-names>L</given-names></name><name><surname>Wallin</surname><given-names>AK</given-names></name><name><surname>Hampel</surname><given-names>H</given-names></name><name><surname>Bürger</surname><given-names>K</given-names></name><name><surname>Pirttila</surname><given-names>T</given-names></name><name><surname>Soininen</surname><given-names>H</given-names></name><name><surname>Rikkert</surname><given-names>MO</given-names></name><name><surname>Verbeek</surname><given-names>MM</given-names></name><name><surname>Spiru</surname><given-names>L</given-names></name><name><surname>Blennow</surname><given-names>K</given-names></name></person-group><article-title>Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study</article-title><source>Lancet Neurol</source><year>2009</year><volume>8</volume><fpage>619</fpage><lpage>627</lpage><pub-id pub-id-type='pmid'>19523877</pub-id></element-citation></ref><ref id='B12'><label>12</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>de Leon</surname><given-names>MJ</given-names></name><name><surname>Mosconi</surname><given-names>L</given-names></name><name><surname>Blennow</surname><given-names>K</given-names></name><name><surname>DeSanti</surname><given-names>S</given-names></name><name><surname>Zinkowski</surname><given-names>R</given-names></name><name><surname>Mehta</surname><given-names>PD</given-names></name><name><surname>Pratico</surname><given-names>D</given-names></name><name><surname>Tsui</surname><given-names>W</given-names></name><name><surname>Saint Louis</surname><given-names>LA</given-names></name><name><surname>Sobanska</surname><given-names>L</given-names></name><name><surname>Brys</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Rich</surname><given-names>K</given-names></name><name><surname>Rinne</surname><given-names>J</given-names></name><name><surname>Rusinek</surname><given-names>H</given-names></name></person-group><article-title>Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease</article-title><source>Ann NY Acad Sci</source><year>2007</year><volume>1097</volume><fpage>114</fpage><lpage>145</lpage><pub-id pub-id-type='pmid'>17413016</pub-id></element-citation></ref><ref id='B13'><label>13</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Borroni</surname><given-names>B</given-names></name><name><surname>Anchisi</surname><given-names>D</given-names></name><name><surname>Paghera</surname><given-names>B</given-names></name><name><surname>Vicini</surname><given-names>B</given-names></name><name><surname>Kerrouche</surname><given-names>N</given-names></name><name><surname>Garibotto</surname><given-names>V</given-names></name><name><surname>Terzi</surname><given-names>A</given-names></name><name><surname>Vignolo</surname><given-names>LA</given-names></name><name><surname>Di Luca</surname><given-names>M</given-names></name><name><surname>Giubbini</surname><given-names>R</given-names></name><name><surname>Oadovani</surname><given-names>A</given-names></name><name><surname>Perani</surname><given-names>D</given-names></name></person-group><article-title>Combined <sup>99m</sup>Tc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD</article-title><source>Neurobiol Aging</source><year>2006</year><volume>27</volume><fpage>24</fpage><lpage>31</lpage><pub-id pub-id-type='pmid'>16298237</pub-id></element-citation></ref><ref id='B14'><label>14</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Wallin</surname><given-names>A</given-names></name><name><surname>Edman</surname><given-names>A</given-names></name><name><surname>Blennow</surname><given-names>K</given-names></name><name><surname>Gottfries</surname><given-names>CG</given-names></name><name><surname>Karlsson</surname><given-names>I</given-names></name><name><surname>Regland</surname><given-names>B</given-names></name><name><surname>Sjogren</surname><given-names>M</given-names></name></person-group><article-title>Stepwise comparative status analysis (step): a tool for identification of regional brain syndromes in dementia</article-title><source>J Geriatr Psychiatry Neurol</source><year>1996</year><volume>9</volume><fpage>185</fpage><lpage>199</lpage><pub-id pub-id-type='pmid'>8970012</pub-id></element-citation></ref><ref id='B15'><label>15</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Royall</surname><given-names>DR</given-names></name><name><surname>Mahurin</surname><given-names>RK</given-names></name><name><surname>Gray</surname><given-names>KF</given-names></name></person-group><article-title>Bedside assessment of executive cognitive impairment: the executive interview</article-title><source>J Am Geriatr Soc</source><year>1992</year><volume>40</volume><fpage>1221</fpage><lpage>1226</lpage><pub-id pub-id-type='pmid'>1447438</pub-id></element-citation></ref><ref id='B16'><label>16</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Folstein</surname><given-names>MF</given-names></name><name><surname>Folstein</surname><given-names>SE</given-names></name><name><surname>McHugh</surname><given-names>PR</given-names></name></person-group><article-title>‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician</article-title><source>J Psychiatric Res</source><year>1975</year><volume>12</volume><fpage>189</fpage><lpage>198</lpage></element-citation></ref><ref id='B17'><label>17</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Morris</surname><given-names>JC</given-names></name></person-group><article-title>Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type</article-title><source>Int Psychogeriatr</source><year>1997</year><volume>9</volume><issue>suppl 1</issue><fpage>173</fpage><lpage>176</lpage><comment>discussion 177–178.</comment><pub-id pub-id-type='pmid'>9447441</pub-id></element-citation></ref><ref id='B18'><label>18</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Nordlund</surname><given-names>A</given-names></name><name><surname>Rolstad</surname><given-names>S</given-names></name><name><surname>Hellstrom</surname><given-names>P</given-names></name><name><surname>Sjogren</surname><given-names>M</given-names></name><name><surname>Hansen</surname><given-names>S</given-names></name><name><surname>Wallin</surname><given-names>A</given-names></name></person-group><article-title>The Göteborg MCI study: mild cognitive impairment is a heterogeneous condition</article-title><source>J Neurol Neurosurg Psychiatry</source><year>2005</year><volume>76</volume><fpage>1485</fpage><lpage>1490</lpage><pub-id pub-id-type='pmid'>16227535</pub-id></element-citation></ref><ref id='B19'><label>19</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Reisberg</surname><given-names>B</given-names></name><name><surname>Ferris</surname><given-names>SH</given-names></name><name><surname>de Leon</surname><given-names>MJ</given-names></name><name><surname>Crook</surname><given-names>T</given-names></name></person-group><article-title>Global deterioration scale (GDS)</article-title><source>Psychopharmacol Bull</source><year>1988</year><volume>24</volume><fpage>661</fpage><lpage>663</lpage><pub-id pub-id-type='pmid'>3249768</pub-id></element-citation></ref><ref id='B20'><label>20</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>McKhann</surname><given-names>G</given-names></name><name><surname>Drachman</surname><given-names>D</given-names></name><name><surname>Folstein</surname><given-names>M</given-names></name><name><surname>Katzman</surname><given-names>R</given-names></name><name><surname>Price</surname><given-names>D</given-names></name><name><surname>Stadlan</surname><given-names>EM</given-names></name></person-group><article-title>Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease</article-title><source>Neurology</source><year>1984</year><volume>34</volume><fpage>939</fpage><lpage>944</lpage><pub-id pub-id-type='pmid'>6610841</pub-id></element-citation></ref><ref id='B21'><label>21</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Erkinjuntti</surname><given-names>T</given-names></name><name><surname>Inzitari</surname><given-names>D</given-names></name><name><surname>Pantoni</surname><given-names>L</given-names></name><name><surname>Wallin</surname><given-names>A</given-names></name><name><surname>Scheltens</surname><given-names>P</given-names></name><name><surname>Rockwood</surname><given-names>K</given-names></name><name><surname>Roman</surname><given-names>GC</given-names></name><name><surname>Chui</surname><given-names>H</given-names></name><name><surname>Desmond</surname><given-names>DW</given-names></name></person-group><article-title>Research criteria for subcortical vascular dementia in clinical trials</article-title><source>J Neural Transm Suppl</source><year>2000</year><volume>59</volume><fpage>23</fpage><lpage>30</lpage><pub-id pub-id-type='pmid'>10961414</pub-id></element-citation></ref><ref id='B22'><label>22</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Neary</surname><given-names>D</given-names></name><name><surname>Snowden</surname><given-names>JS</given-names></name><name><surname>Gustafson</surname><given-names>L</given-names></name><name><surname>Passant</surname><given-names>U</given-names></name><name><surname>Stuss</surname><given-names>D</given-names></name><name><surname>Black</surname><given-names>S</given-names></name><name><surname>Freedman</surname><given-names>M</given-names></name><name><surname>Kertesz</surname><given-names>A</given-names></name><name><surname>Robert</surname><given-names>PH</given-names></name><name><surname>Albert</surname><given-names>M</given-names></name><name><surname>Boone</surname><given-names>K</given-names></name><name><surname>Miller</surname><given-names>BL</given-names></name><name><surname>Cummings</surname><given-names>J</given-names></name><name><surname>Benson</surname><given-names>DF</given-names></name></person-group><article-title>Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria</article-title><source>Neurology</source><year>1998</year><volume>51</volume><fpage>1546</fpage><lpage>1554</lpage><pub-id pub-id-type='pmid'>9855500</pub-id></element-citation></ref><ref id='B23'><label>23</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Huang</surname><given-names>C</given-names></name><name><surname>Wahlund</surname><given-names>LO</given-names></name><name><surname>Almkvist</surname><given-names>O</given-names></name><name><surname>Elehu</surname><given-names>D</given-names></name><name><surname>Svensson</surname><given-names>L</given-names></name><name><surname>Jonsson</surname><given-names>T</given-names></name><name><surname>Winblad</surname><given-names>B</given-names></name><name><surname>Julin</surname><given-names>P</given-names></name></person-group><article-title>Voxel- and VOI-based analysis of SPECT CBF in relation to clinical and psychological heterogeneity of mild cognitive impairment</article-title><source>Neuroimage</source><year>2003</year><volume>19</volume><fpage>1137</fpage><lpage>1144</lpage><pub-id pub-id-type='pmid'>12880839</pub-id></element-citation></ref><ref id='B24'><label>24</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Huang</surname><given-names>C</given-names></name><name><surname>Eidelberg</surname><given-names>D</given-names></name><name><surname>Habeck</surname><given-names>C</given-names></name><name><surname>Moeller</surname><given-names>J</given-names></name><name><surname>Svensson</surname><given-names>L</given-names></name><name><surname>Tarabula</surname><given-names>T</given-names></name><name><surname>Julin</surname><given-names>P</given-names></name></person-group><article-title>Imaging markers of mild cognitive impairment: multivariate analysis of CBF SPECT</article-title><source>Neurobiol Aging</source><year>2007</year><volume>28</volume><fpage>1062</fpage><lpage>1069</lpage><pub-id pub-id-type='pmid'>16824650</pub-id></element-citation></ref><ref id='B25'><label>25</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Matsuda</surname><given-names>H</given-names></name></person-group><article-title>The role of neuroimaging in mild cognitive impairment</article-title><source>Neuropathology</source><year>2007</year><volume>27</volume><fpage>570</fpage><lpage>577</lpage><pub-id pub-id-type='pmid'>18021379</pub-id></element-citation></ref><ref id='B26'><label>26</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Hansson</surname><given-names>O</given-names></name><name><surname>Buchhave</surname><given-names>P</given-names></name><name><surname>Zetterberg</surname><given-names>H</given-names></name><name><surname>Blennow</surname><given-names>K</given-names></name><name><surname>Minthon</surname><given-names>L</given-names></name><name><surname>Warkentin</surname><given-names>S</given-names></name></person-group><article-title>Combined rCBF and CSF biomarkers predict progression from mild cognitive impairment to Alzheimer's disease</article-title><source>Neurobiol Aging</source><year>2009</year><volume>30</volume><fpage>165</fpage><lpage>173</lpage><pub-id pub-id-type='pmid'>17646035</pub-id></element-citation></ref><ref id='B27'><label>27</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>McEvoy</surname><given-names>LK</given-names></name><name><surname>Fennema-Notestine</surname><given-names>C</given-names></name><name><surname>Roddey</surname><given-names>JC</given-names></name><name><surname>Hagler</surname><given-names>DJ</given-names><suffix>Jr</suffix></name><name><surname>Holland</surname><given-names>D</given-names></name><name><surname>Karow</surname><given-names>DS</given-names></name><name><surname>Pung</surname><given-names>CJ</given-names></name><name><surname>Brewer</surname><given-names>JB</given-names></name><name><surname>Dale</surname><given-names>AM</given-names></name></person-group><article-title>Alzheimer's Disease Neuroimaging Initiative: Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment</article-title><source>Radiology</source><year>2009</year><volume>251</volume><fpage>195</fpage><lpage>205</lpage><pub-id pub-id-type='pmid'>19201945</pub-id></element-citation></ref><ref id='B28'><label>28</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Huang</surname><given-names>C</given-names></name><name><surname>Wahlund</surname><given-names>LO</given-names></name><name><surname>Svensson</surname><given-names>L</given-names></name><name><surname>Winblad</surname><given-names>B</given-names></name><name><surname>Julin</surname><given-names>P</given-names></name></person-group><article-title>Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment</article-title><source>BMC Neurol</source><year>2002</year><volume>2</volume><fpage>9</fpage><pub-id pub-id-type='pmid'>12227833</pub-id></element-citation></ref><ref id='B29'><label>29</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Nobili</surname><given-names>F</given-names></name><name><surname>Frisoni</surname><given-names>GB</given-names></name><name><surname>Portet</surname><given-names>F</given-names></name><name><surname>Verhey</surname><given-names>F</given-names></name><name><surname>Rodriguez</surname><given-names>G</given-names></name><name><surname>Caroli</surname><given-names>A</given-names></name><name><surname>Touchon</surname><given-names>J</given-names></name><name><surname>Calvini</surname><given-names>P</given-names></name><name><surname>Morbelli</surname><given-names>S</given-names></name><name><surname>De Carli</surname><given-names>F</given-names></name><name><surname>Guerra</surname><given-names>UP</given-names></name><name><surname>Van de Pol</surname><given-names>LA</given-names></name><name><surname>Visser</surname><given-names>PJ</given-names></name></person-group><article-title>Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study</article-title><source>J Neurol</source><year>2008</year><volume>255</volume><fpage>1344</fpage><lpage>1353</lpage><pub-id pub-id-type='pmid'>18958573</pub-id></element-citation></ref><ref id='B30'><label>30</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Habert</surname><given-names>MO</given-names></name><name><surname>Horn</surname><given-names>JF</given-names></name><name><surname>Sarazin</surname><given-names>M</given-names></name><name><surname>Lotterie</surname><given-names>JA</given-names></name><name><surname>Puel</surname><given-names>M</given-names></name><name><surname>Onen</surname><given-names>F</given-names></name><name><surname>Zanca</surname><given-names>M</given-names></name><name><surname>Portet</surname><given-names>F</given-names></name><name><surname>Touchon</surname><given-names>J</given-names></name><name><surname>Verny</surname><given-names>M</given-names></name><name><surname>Mahieeux</surname><given-names>F</given-names></name><name><surname>Giron</surname><given-names>A</given-names></name><name><surname>Fertil</surname><given-names>B</given-names></name><name><surname>Dubois</surname><given-names>B</given-names></name></person-group><article-title>Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer's disease among patients with mild cognitive impairment</article-title><source>Neurobiol Aging</source><year>2011</year><volume>32</volume><fpage>15</fpage><lpage>23</lpage><pub-id pub-id-type='pmid'>19250707</pub-id></element-citation></ref><ref id='B31'><label>31</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Dai</surname><given-names>W</given-names></name><name><surname>Lopez</surname><given-names>OL</given-names></name><name><surname>Carmichael</surname><given-names>OT</given-names></name><name><surname>Becker</surname><given-names>JT</given-names></name><name><surname>Kuller</surname><given-names>LH</given-names></name><name><surname>Gach</surname><given-names>HM</given-names></name></person-group><article-title>Mild cognitive impairment and Alzheimer disease: patterns of altered cerebral blood flow at MR imaging</article-title><source>Radiology</source><year>2009</year><volume>250</volume><fpage>856</fpage><lpage>866</lpage><pub-id pub-id-type='pmid'>19164119</pub-id></element-citation></ref><ref id='B32'><label>32</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Guedj</surname><given-names>E</given-names></name><name><surname>Barbeau</surname><given-names>EJ</given-names></name><name><surname>Didic</surname><given-names>M</given-names></name><name><surname>Felician</surname><given-names>O</given-names></name><name><surname>de Laforte</surname><given-names>C</given-names></name><name><surname>Ranjeva</surname><given-names>JP</given-names></name><name><surname>Poncet</surname><given-names>M</given-names></name><name><surname>Cozzone</surname><given-names>PJ</given-names></name><name><surname>Mundler</surname><given-names>O</given-names></name><name><surname>Ceccaldi</surname><given-names>M</given-names></name></person-group><article-title>Effects of medial temporal lobe degeneration on brain perfusion in amnestic MCI of AD type: deafferentation and functional compensation?</article-title><source>Eur J Nucl Med Mol Imaging</source><year>2009</year><volume>36</volume><fpage>1101</fpage><lpage>1112</lpage><pub-id pub-id-type='pmid'>19224210</pub-id></element-citation></ref><ref id='B33'><label>33</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Yuan</surname><given-names>Y</given-names></name><name><surname>Gu</surname><given-names>ZX</given-names></name><name><surname>Wei</surname><given-names>WS</given-names></name></person-group><article-title>Fluorodeoxyglucose-positron-emission tomography, single-photon emission tomography, and structural MR imaging for prediction of rapid conversion to Alzheimer disease in patients with mild cognitive impairment: a meta-analysis</article-title><source>Am J Neuroradiol</source><year>2009</year><volume>30</volume><fpage>404</fpage><lpage>410</lpage><pub-id pub-id-type='pmid'>19001534</pub-id></element-citation></ref><ref id='B34'><label>34</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Mosconi</surname><given-names>L</given-names></name><name><surname>De Santi</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Tsui</surname><given-names>WH</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Boppana</surname><given-names>M</given-names></name><name><surname>Laska</surname><given-names>E</given-names></name><name><surname>Rusinek</surname><given-names>H</given-names></name><name><surname>de Leon</surname><given-names>MJ</given-names></name></person-group><article-title>Hippocampal hypometabolism predicts cognitive decline from normal aging</article-title><source>Neurobiol Aging</source><year>2008</year><volume>29</volume><fpage>676</fpage><lpage>692</lpage><pub-id pub-id-type='pmid'>17222480</pub-id></element-citation></ref><ref id='B35'><label>35</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Forsberg</surname><given-names>A</given-names></name><name><surname>Engler</surname><given-names>H</given-names></name><name><surname>Almkvist</surname><given-names>O</given-names></name><name><surname>Blomquist</surname><given-names>G</given-names></name><name><surname>Hagman</surname><given-names>G</given-names></name><name><surname>Wall</surname><given-names>A</given-names></name><name><surname>Ringheim</surname><given-names>A</given-names></name><name><surname>Långström</surname><given-names>B</given-names></name><name><surname>Nordberg</surname><given-names>A</given-names></name></person-group><article-title>PET imaging of amyloid deposition in patients with mild cognitive impairment</article-title><source>Neurobiol Aging</source><year>2008</year><volume>29</volume><fpage>1456</fpage><lpage>1465</lpage><pub-id pub-id-type='pmid'>17499392</pub-id></element-citation></ref><ref id='B36'><label>36</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Sojkova</surname><given-names>J</given-names></name><name><surname>Beason-Held</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>An</surname><given-names>Y</given-names></name><name><surname>Kraut</surname><given-names>MA</given-names></name><name><surname>Ye</surname><given-names>W</given-names></name><name><surname>Ferrucci</surname><given-names>L</given-names></name><name><surname>Mathis</surname><given-names>CA</given-names></name><name><surname>Klunk</surname><given-names>WE</given-names></name><name><surname>Wong</surname><given-names>DF</given-names></name><name><surname>Resnick</surname><given-names>SM</given-names></name></person-group><article-title>Longitudinal cerebral blood flow and amyloid deposition: an emerging pattern?</article-title><source>J Nucl Med</source><year>2008</year><volume>49</volume><fpage>1465</fpage><lpage>1471</lpage><pub-id pub-id-type='pmid'>18703614</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap orientation='portrait' id='T1' position='float'><label>Table 1</label><caption><p>Demographic data and MMSE scores at baseline</p></caption><table rules='groups' frame='hsides'><thead><tr valign='bottom'><th colspan='1' rowspan='1'></th><th colspan='1' rowspan='1'></th><th colspan='1' rowspan='1' align='left'>PMCI</th><th colspan='1' rowspan='1' align='left'>SMCI</th></tr></thead><tbody><tr valign='top'><td colspan='1' rowspan='1' align='left'>Age, years</td><td colspan='1' rowspan='1' align='left'>Mean</td><td colspan='1' rowspan='1' char='.' align='char'>66.9</td><td colspan='1' rowspan='1' char='.' align='char'>66.5</td></tr><tr valign='top'><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1' align='left'>SD</td><td colspan='1' rowspan='1' char='.' align='char'>6.7</td><td colspan='1' rowspan='1' char='.' align='char'>7.4</td></tr><tr valign='top'><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1' align='left'>Range</td><td colspan='1' rowspan='1' char='.' align='char'>51-78</td><td colspan='1' rowspan='1' char='.' align='char'>54-77</td></tr><tr><td colspan='4' rowspan='1'><hr></hr></td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Gender</td><td colspan='1' rowspan='1' align='left'>Males</td><td colspan='1' rowspan='1' char='.' align='char'>8</td><td colspan='1' rowspan='1' char='.' align='char'>11</td></tr><tr valign='top'><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1' align='left'>Females</td><td colspan='1' rowspan='1' char='.' align='char'>11</td><td colspan='1' rowspan='1' char='.' align='char'>7</td></tr><tr><td colspan='4' rowspan='1'><hr></hr></td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>MMSE</td><td colspan='1' rowspan='1' align='left'>Mean</td><td colspan='1' rowspan='1' char='.' align='char'>27.3</td><td colspan='1' rowspan='1' char='.' align='char'>28.1</td></tr><tr valign='top'><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1' align='left'>SD</td><td colspan='1' rowspan='1' char='.' align='char'>1.5</td><td colspan='1' rowspan='1' char='.' align='char'>1.7</td></tr><tr valign='top'><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1' align='left'>Range</td><td colspan='1' rowspan='1' char='.' align='char'>23-29</td><td colspan='1' rowspan='1' char='.' align='char'>24-30</td></tr></tbody></table></table-wrap><table-wrap orientation='portrait' id='T2' position='float'><label>Table 2</label><caption><p>Number of patients with significantly decreased blood flow in 10 brain regions [frontal lobe (right, left, medial), temporal lobe (right, left, right medial, left medial), parietal lobe (right, left) and occipital lobe]</p></caption><table rules='groups' frame='hsides'><thead><tr valign='bottom'><th colspan='1' rowspan='1' align='left'>Normalization</th><th colspan='2' rowspan='1' align='left'>Cortex<hr></hr></th><th colspan='2' rowspan='1' align='left'>Cerebellum<sub>tot</sub><hr></hr></th><th colspan='2' rowspan='1' align='left'>Cerebellum<sub>max</sub><hr></hr></th></tr><tr valign='bottom'><th colspan='1' rowspan='1'></th><th colspan='1' rowspan='1' align='left'>PMCI (n=19)</th><th colspan='1' rowspan='1' align='left'>SMCI (n=18)</th><th colspan='1' rowspan='1' align='left'>PMCI (n=19)</th><th colspan='1' rowspan='1' align='left'>SMCI (n=18)</th><th colspan='1' rowspan='1' align='left'>PMCI (n=19)</th><th colspan='1' rowspan='1' align='left'>SMCI (n=18)</th></tr></thead><tbody><tr valign='top'><td colspan='1' rowspan='1' align='left'>Frontal dx</td><td colspan='1' rowspan='1' align='left'>0</td><td colspan='1' rowspan='1' align='left'>0</td><td colspan='1' rowspan='1' align='left'>1</td><td colspan='1' rowspan='1' align='left'>1</td><td colspan='1' rowspan='1' align='left'>1</td><td colspan='1' rowspan='1' align='left'>0</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Frontal sin</td><td colspan='1' rowspan='1' align='left'>3</td><td colspan='1' rowspan='1' align='left'>2</td><td colspan='1' rowspan='1' align='left'>4</td><td colspan='1' rowspan='1' align='left'>2</td><td colspan='1' rowspan='1' align='left'>2</td><td colspan='1' rowspan='1' align='left'>2</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Frontal med</td><td colspan='1' rowspan='1' align='left'>0</td><td colspan='1' rowspan='1' align='left'>0</td><td colspan='1' rowspan='1' align='left'>1</td><td colspan='1' rowspan='1' align='left'>0</td><td colspan='1' rowspan='1' align='left'>1</td><td colspan='1' rowspan='1' align='left'>2</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Temporal dx</td><td colspan='1' rowspan='1' align='left'>0</td><td colspan='1' rowspan='1' align='left'>0</td><td colspan='1' rowspan='1' align='left'>1</td><td colspan='1' rowspan='1' align='left'>1</td><td colspan='1' rowspan='1' align='left'>1</td><td colspan='1' rowspan='1' align='left'>1</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Temporal sin</td><td colspan='1' rowspan='1' align='left'>1</td><td colspan='1' rowspan='1' align='left'>1</td><td colspan='1' rowspan='1' align='left'>2</td><td colspan='1' rowspan='1' align='left'>2</td><td colspan='1' rowspan='1' align='left'>1</td><td colspan='1' rowspan='1' align='left'>1</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Temporal med dx</td><td colspan='1' rowspan='1' align='left'>3</td><td colspan='1' rowspan='1' align='left'>2</td><td colspan='1' rowspan='1' align='left'>5</td><td colspan='1' rowspan='1' align='left'>3</td><td colspan='1' rowspan='1' align='left'>5</td><td colspan='1' rowspan='1' align='left'>1</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Temporal med sin</td><td colspan='1' rowspan='1' align='left'>5</td><td colspan='1' rowspan='1' align='left'>3</td><td colspan='1' rowspan='1' align='left'>8</td><td colspan='1' rowspan='1' align='left'>2</td><td colspan='1' rowspan='1' align='left'>8<xref rid='T2F1' ref-type='table-fn'><sup>*</sup></xref></td><td colspan='1' rowspan='1' align='left'>1<xref rid='T2F1' ref-type='table-fn'><sup>*</sup></xref></td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Parietal dx</td><td colspan='1' rowspan='1' align='left'>7</td><td colspan='1' rowspan='1' align='left'>5</td><td colspan='1' rowspan='1' align='left'>7</td><td colspan='1' rowspan='1' align='left'>2</td><td colspan='1' rowspan='1' align='left'>6</td><td colspan='1' rowspan='1' align='left'>4</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Parietal sin</td><td colspan='1' rowspan='1' align='left'>8</td><td colspan='1' rowspan='1' align='left'>9</td><td colspan='1' rowspan='1' align='left'>9</td><td colspan='1' rowspan='1' align='left'>4</td><td colspan='1' rowspan='1' align='left'>6</td><td colspan='1' rowspan='1' align='left'>4</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Occipital</td><td colspan='1' rowspan='1' align='left'>1</td><td colspan='1' rowspan='1' align='left'>0</td><td colspan='1' rowspan='1' align='left'>1</td><td colspan='1' rowspan='1' align='left'>2</td><td colspan='1' rowspan='1' align='left'>0</td><td colspan='1' rowspan='1' align='left'>2</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Total</td><td colspan='1' rowspan='1' align='left'>16</td><td colspan='1' rowspan='1' align='left'>13</td><td colspan='1' rowspan='1' align='left'>12</td><td colspan='1' rowspan='1' align='left'>8</td><td colspan='1' rowspan='1' align='left'>12<xref rid='T2F2' ref-type='table-fn'><sup>**</sup></xref></td><td colspan='1' rowspan='1' align='left'>5<xref rid='T2F2' ref-type='table-fn'><sup>**</sup></xref></td></tr></tbody></table><table-wrap-foot><fn><p>Cortex, cerebellum<sub>tot</sub>, cerebellum<sub>max</sub>: reference regions for blood flow calculation (see Image Analysis above).</p></fn><fn id='T2F1'><label>*</label><p>p = 0.019</p></fn><fn id='T2F2'><label>**</label><p>p = 0.049.</p></fn></table-wrap-foot></table-wrap><table-wrap orientation='portrait' id='T3' position='float'><label>Table 3</label><caption><p>Blood flow in relation to a normal database presented in z-values (standard deviations from mean)</p></caption><table rules='groups' frame='hsides'><thead><tr valign='bottom'><th colspan='1' rowspan='1' align='left'>Normalization</th><th colspan='2' rowspan='1' align='left'>Cortex<hr></hr></th><th colspan='2' rowspan='1' align='left'>Cerebellum<sub>tot</sub><hr></hr></th><th colspan='2' rowspan='1' align='left'>Cerebellum<sub>max</sub><hr></hr></th></tr><tr valign='bottom'><th colspan='1' rowspan='1'></th><th colspan='1' rowspan='1' align='left'>PMCI (n=19)</th><th colspan='1' rowspan='1' align='left'>SMCI (n=18)</th><th colspan='1' rowspan='1' align='left'>PMCI (n=19)</th><th colspan='1' rowspan='1' align='left'>SMCI (n=18)</th><th colspan='1' rowspan='1' align='left'>PMCI (n=19)</th><th colspan='1' rowspan='1' align='left'>SMCI (n=18)</th></tr></thead><tbody><tr valign='top'><td colspan='1' rowspan='1' align='left'>Frontal dx</td><td colspan='1' rowspan='1' align='left'>0.68+1.48</td><td colspan='1' rowspan='1' align='left'>0.32+0.88</td><td colspan='1' rowspan='1' align='left'>−0.24+1.29</td><td colspan='1' rowspan='1' align='left'>−0.27+0.89</td><td colspan='1' rowspan='1' align='left'>−0.35+0.95</td><td colspan='1' rowspan='1' align='left'>−0.27+0.92</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Frontal sin</td><td colspan='1' rowspan='1' align='left'>−0.78+1.17</td><td colspan='1' rowspan='1' align='left'>−0.76+0.70</td><td colspan='1' rowspan='1' align='left'>−0.93+1.10</td><td colspan='1' rowspan='1' align='left'>−0.78+0.81</td><td colspan='1' rowspan='1' align='left'>−0.92+0.86</td><td colspan='1' rowspan='1' align='left'>−0.70+0.87</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Frontal med</td><td colspan='1' rowspan='1' align='left'>−0.33+0.76</td><td colspan='1' rowspan='1' align='left'>−0.34+0.93</td><td colspan='1' rowspan='1' align='left'>−0.63+0.89</td><td colspan='1' rowspan='1' align='left'>−0.54+0.87</td><td colspan='1' rowspan='1' align='left'>−0.71+0.82</td><td colspan='1' rowspan='1' align='left'>−0.55+1.06</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Temporal dx</td><td colspan='1' rowspan='1' align='left'>1.21+1.26</td><td colspan='1' rowspan='1' align='left'>1.31+0.85</td><td colspan='1' rowspan='1' align='left'>0.16+1.39</td><td colspan='1' rowspan='1' align='left'>0.39+1.21</td><td colspan='1' rowspan='1' align='left'>−0.02+1.04</td><td colspan='1' rowspan='1' align='left'>0.26+1.13</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Temporal sin</td><td colspan='1' rowspan='1' align='left'>0.03+1.52</td><td colspan='1' rowspan='1' align='left'>0.12+0.91</td><td colspan='1' rowspan='1' align='left'>−0.58+1.35</td><td colspan='1' rowspan='1' align='left'>−0.36+1.12</td><td colspan='1' rowspan='1' align='left'>−0.59+1.13</td><td colspan='1' rowspan='1' align='left'>−0.33+1.04</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Temporal med dx</td><td colspan='1' rowspan='1' align='left'>−0.99+0.85</td><td colspan='1' rowspan='1' align='left'>−0.79+1.03</td><td colspan='1' rowspan='1' align='left'>−1.20+1.01</td><td colspan='1' rowspan='1' align='left'>−0.94+0.85</td><td colspan='1' rowspan='1' align='left'>−1.18+1.01</td><td colspan='1' rowspan='1' align='left'>−0.88+0.83</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Temporal med sin</td><td colspan='1' rowspan='1' align='left'>−1.55+1.80</td><td colspan='1' rowspan='1' align='left'>−1.31+0.73</td><td colspan='1' rowspan='1' align='left'>−1.60+1.51</td><td colspan='1' rowspan='1' align='left'>−1.32+0.60</td><td colspan='1' rowspan='1' align='left'>−1.52+1.49</td><td colspan='1' rowspan='1' align='left'>−1.21+0.74</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Parietal dx</td><td colspan='1' rowspan='1' align='left'>−1.77+0.95</td><td colspan='1' rowspan='1' align='left'>−1.44+0.97</td><td colspan='1' rowspan='1' align='left'>−1.68+0.92</td><td colspan='1' rowspan='1' align='left'>−1.35+0.86</td><td colspan='1' rowspan='1' align='left'>−1.51+0.68</td><td colspan='1' rowspan='1' align='left'>−1.17+0.83</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Parietal sin</td><td colspan='1' rowspan='1' align='left'>−1.97+1.08</td><td colspan='1' rowspan='1' align='left'>−1.60+1.03</td><td colspan='1' rowspan='1' align='left'>−1.82+1.03</td><td colspan='1' rowspan='1' align='left'>−1.46+0.84</td><td colspan='1' rowspan='1' align='left'>−1.63+0.84</td><td colspan='1' rowspan='1' align='left'>−1.27+0.86</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Occipital</td><td colspan='1' rowspan='1' align='left'>−0.43+1.17</td><td colspan='1' rowspan='1' align='left'>−0.70+0.63</td><td colspan='1' rowspan='1' align='left'>−0.86+0.72</td><td colspan='1' rowspan='1' align='left'>−0.89+0.83</td><td colspan='1' rowspan='1' align='left'>−0.80+0.61</td><td colspan='1' rowspan='1' align='left'>−0.75+0.87</td></tr></tbody></table><table-wrap-foot><fn><p>No differences in mean values between PMCI and SMCI were statistically significant (t test).</p></fn></table-wrap-foot></table-wrap><table-wrap orientation='portrait' id='T4' position='float'><label>Table 4</label><caption><p>Number of patients with significant side differences in cerebral blood flow with regard to frontal, temporal, and parietal lobes, respectively</p></caption><table rules='groups' frame='hsides'><thead><tr valign='bottom'><th colspan='1' rowspan='1' align='left'>Lobes</th><th colspan='2' rowspan='1' align='left'>PMCI (n= 19)<hr></hr></th><th colspan='2' rowspan='1' align='left'>SMCI (n = 18)<hr></hr></th><th colspan='1' rowspan='1' align='left'>p value<hr></hr></th><th colspan='1' rowspan='1'><hr></hr></th></tr><tr valign='bottom'><th colspan='1' rowspan='1'></th><th colspan='1' rowspan='1' align='left'>L&lt;R</th><th colspan='1' rowspan='1' align='left'>R&lt;L</th><th colspan='1' rowspan='1' align='left'>L&lt;R</th><th colspan='1' rowspan='1' align='left'>R&lt;L</th><th colspan='1' rowspan='1' align='left'>PMCI vs. SMCI</th><th colspan='1' rowspan='1' align='left'>L&lt;Rvs. R&lt;L</th></tr></thead><tbody><tr valign='top'><td colspan='1' rowspan='1' align='left'>Frontal</td><td colspan='1' rowspan='1' align='left'>7</td><td colspan='1' rowspan='1' align='left'>0</td><td colspan='1' rowspan='1' align='left'>4</td><td colspan='1' rowspan='1' align='left'>0</td><td colspan='1' rowspan='1' align='left'>NS</td><td colspan='1' rowspan='1' align='left'>0.003</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Temporal</td><td colspan='1' rowspan='1' align='left'>4</td><td colspan='1' rowspan='1' align='left'>0</td><td colspan='1' rowspan='1' align='left'>0</td><td colspan='1' rowspan='1' align='left'>0</td><td colspan='1' rowspan='1' align='left'>NS</td><td colspan='1' rowspan='1' align='left'>NS</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Parietal</td><td colspan='1' rowspan='1' align='left'>1</td><td colspan='1' rowspan='1' align='left'>0</td><td colspan='1' rowspan='1' align='left'>0</td><td colspan='1' rowspan='1' align='left'>0</td><td colspan='1' rowspan='1' align='left'>NS</td><td colspan='1' rowspan='1' align='left'>NS</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Total</td><td colspan='1' rowspan='1' align='left'>7</td><td colspan='1' rowspan='1' align='left'>0</td><td colspan='1' rowspan='1' align='left'>4</td><td colspan='1' rowspan='1' align='left'>0</td><td colspan='1' rowspan='1' align='left'>NS</td><td colspan='1' rowspan='1' align='left'>0.003</td></tr></tbody></table><table-wrap-foot><fn><p>Total: number of patients with significant side difference in at least 1 region. L &lt; R and R &lt; L = Significantly lower cerebral blood flow in the left region than in the right region and vice versa.</p></fn></table-wrap-foot></table-wrap></floats-group></article></PAPER>